临床肿瘤学杂志

• 临床应用 • 上一篇    下一篇

以CD56+小肠粒细胞肉瘤为首发表现的急性单核细胞白血病1例并文献复习

徐喜慧,欧阳建,徐 勇,陈 兵,周荣富,许景艳,张启国,杨永公,邵晓雁,关朝阳
  

  1. 210008 南京 南京大学医学院附属南京市鼓楼医院血液科
  • 收稿日期:2012-08-27 修回日期:2012-12-30 出版日期:2013-03-31 发布日期:2013-03-31
  • 通讯作者: 欧阳建

Small bowel granulocytic sarcoma with CD56+ as a presenting sign of acute monocytic leukemia:1 case report and review of literatures

XU Xihui,OUYANG Jian,XU Yong,CHEN Bing,ZHOU Rongfu,XU Jingyan,ZHANG Qiguo,YANG Yonggong,SHAO Xiaoyan,GUAN Chaoyang.   

  1. Department of Hematology,Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China
  • Received:2012-08-27 Revised:2012-12-30 Online:2013-03-31 Published:2013-03-31
  • Contact: OUYANG Jian

摘要:

目的 探讨粒细胞肉瘤的发病机制、诊治与转归。方法分析1例以CD56+小肠粒细胞肉瘤为首发表现的急性单核细胞白血病患者的临床病理特征及实验室检查结果,并复习相关文献。结果 收治1例男性患者,39岁。小肠系膜切除物免疫组化检测示:粒细胞肉瘤,CD56阳性;骨髓细胞学检查示:急性单核细胞白血病,诊断为急性单核细胞白血病伴小肠粒细胞肉瘤。经IA方案诱导化疗后疾病达完全缓解,继续IA方案巩固化疗,拟行异基因造血干细胞移植。结论以小肠粒细胞肉瘤为首发表现的急性白血病较为少见。粒细胞肉瘤的预后差,CD56抗原阳性提示预后不良,经诱导化疗获疾病缓解的患者应尽快行异基因造血干细胞移植以期达到长期生存。

Abstract: Objective To explore the pathogenesis,diagnosis,treatment and outcome of granulocytic sarcomas. Methods A middle aged male patient with CD56+granulocytic sarcoma in his small bowel as the first presenting sign of acute monocytic leukemia was reported and the relevant literatures were reviewed. Results The male patient was 39 years old. The immunohistochemical findings of small bowel mesenteric excision showed granulocytic sarcoma with positive CD56 antigen. Bone marrow cytology examination showed the feature of acute monocytic leukemia. The patient was diagnosed with acute monocytic leukemia with small intestine myeloid sarcoma. The patient achieved complete hematology remission after IA therapy, and the consolidation chemotherapy of IA regimen was followed then. The allogeneic hematopoietic stem cell transplantation would be applied. Conclusion The acute leukemia with the small bowel granulocytic sarcoma as the first presenting sign is relatively rare. The prognosis of granulocytic sarcoma is poor. CD56 antigen probably suggested the patients poor prognosis. So patient after remission should be as soon as possible to be treated by allogeneic hematopoietic stem cell transplantation in order to achieve the long term survival.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!